litlas
Log inCreate account

Ying Yuan

Active 1988–2026

562
Papers
29,351
Citations
94
h-index
410
i10-index

Citations

Citations per year for Ying Yuan1986: 1 citations1990: 1 citations1991: 6 citations1992: 1 citations1993: 9 citations1994: 4 citations1995: 12 citations1996: 21 citations1997: 28 citations1998: 39 citations1999: 28 citations2000: 59 citations2001: 65 citations2002: 62 citations2003: 57 citations2004: 49 citations2005: 55 citations2006: 46 citations2007: 55 citations2008: 60 citations2009: 70 citations2010: 63 citations2011: 66 citations2012: 85 citations2013: 108 citations2014: 126 citations2015: 113 citations2016: 146 citations2017: 183 citations2018: 191 citations2019: 522 citations2020: 800 citations2021: 1,026 citations2022: 1,131 citations2023: 1,003 citations2024: 1,951 citations2025: 1,274 citations2026: 100 citations1987–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,403 citing papers, 26.3% of this breakdownUnited States: 2,707 citing papers, 20.9% of this breakdownUnited Kingdom: 634 citing papers, 4.9% of this breakdownGermany: 463 citing papers, 3.6% of this breakdownItaly: 456 citing papers, 3.5% of this breakdownIndia: 381 citing papers, 2.9% of this breakdownFrance: 361 citing papers, 2.8% of this breakdownCanada: 343 citing papers, 2.7% of this breakdownAustralia: 300 citing papers, 2.3% of this breakdownNetherlands: 265 citing papers, 2% of this breakdownJapan: 263 citing papers, 2% of this breakdownSouth Korea: 244 citing papers, 1.9% of this breakdown
0%26.3%Other 24.2%

Institutions

Fields

  • Medicine49.8%
  • Biochemistry, Genetics and Molecular Biology20.2%
  • Computer Science7.3%
  • Immunology and Microbiology5.4%
  • Engineering4.2%
  • Neuroscience3.4%
  • Other9.7%

Topics

  • Cancer Immunotherapy and Biomarkers3.5%
  • Tuberculosis Research and Epidemiology2.6%
  • Glioma Diagnosis and Treatment1.7%
  • CAR-T cell therapy research1.7%
  • Mycobacterium research and diagnosis1.5%
  • Immune cells in cancer1.2%
  • Other87.8%

Coauthors

All papers

Open in search
  1. Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

    Authors: Jing Huang, Jianming Xu, Yun Chen, Wu Zhuang, Yiping Zhang, Zhendong Chen, Jia Chen, Helong Zhang, Zuoxing Niu, Qingxia Fan, Lizhu Lin, Kangsheng Gu, Ying Liu, Yi Ba, Zhanhui Miao, Xiaodong Jiang, Ming Zeng, Jianhua Chen, Zhichao Fu, Lu Gan, Jun Wang, Xianbao Zhan, Tianshu Liu, Zhiping Li, Lin Shen, Yongqian Shu, Tao Zhang, Qing Yang, Jianjun Zou, Suxia Luo, Feng Peng, Gang Wu, Nong Xu, Lin Zhao, Dong Ma, Shukui Qin, Wei Ren, Enxiao Li, Hongda Lu, Yueyin Pan, Jianping Xiong, Ying Yuan, Yuxian Bai, Lei Chen, Yi Hu, Li Zhang, Yong Gao - The Lancet Oncology 2020 cited by 584

  2. Generalizable Humanoid Manipulation with Improved 3D Diffusion Policies

    Authors: Yanjie Ze, Zixuan Chen, Wenhao Wang, Tianyi Chen, Xialin He, Ying Yuan, Xue Bin Peng, Jiajun Wu - IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) 2025 cited by 74

  3. Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer

    Authors: Jin Li, Shukui Qin, Rui‐Hua Xu, Lin Shen, Jianming Xu, Yuxian Bai, Lei Yang, Yanhong Deng, Zhen-dong Chen, Haijun Zhong, Hongming Pan, Weijian Guo, Yongqian Shu, Ying Yuan, Jianfeng Zhou, Nong Xu, Tianshu Liu, Dong Ma, Changping Wu, Ying Cheng, Donghui Chen, Wei Li, Sanyuan Sun, Zhuang Yu, Peiguo Cao, Haihui Chen, Jiejun Wang, Shubin Wang, Hongbing Wang, Songhua Fan, Hua Ye, Weiguo Su - JAMA 2018 cited by 404

  4. GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy

    Authors: Yinshuang Li, Ying Yuan, Zhongxing Huang, Hui Chen, Ruilong Lan, Zeng Wang, Kunmei Lai, Hong Chen, Zhimin Chen, Zhenhuan Zou, Huabin Ma, Hui Y. Lan, Tak W. Mak, Yanfang Xu - Cell Death and Differentiation 2021 cited by 208

  5. Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

    Authors: Jing Pan, Yue Tan, Guoling Wang, Biping Deng, Zhuojun Ling, Weiliang Song, Samuel Seery, Yanlei Zhang, Shuixiu Peng, Jinlong Xu, Jiajia Duan, Zelin Wang, Xinjian Yu, Qinlong Zheng, Xiuwen Xu, Ying Yuan, Fangrong Yan, Zhenglong Tian, Kaiting Tang, Jiecheng Zhang, Alex H. Chang, Xiaoming Feng - Journal of Clinical Oncology 2021 cited by 294

  6. Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses

    Authors: Jun Liu, Ying Yuan, Wenna Chen, Juan Putra, Arief A. Suriawinata, Austin Schenk, Halli E. Miller, Indira Guleria, Richard J. Barth, Yina H. Huang, Li Wang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 365

  7. GSDMD-dependent neutrophil extracellular traps promote macrophage-to-myofibroblast transition and renal fibrosis in obstructive nephropathy

    Authors: Yujia Wang, Yinshuang Li, Zhimin Chen, Ying Yuan, SU Qing-lin, Keng Ye, Caiming Chen, Guoping Li, Yankun Song, Hong Chen, Yanfang Xu - Cell Death and Disease 2022 cited by 116

  8. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell–Mediated Inflammation and Immunosuppression

    Authors: Wenwen Xu, Juan Dong, Yongwei Zheng, Juan Zhou, Ying Yuan, Hieu Minh Ta, Halli E. Miller, Michael Olson, Kamalakannan Rajasekaran, Marc S. Ernstoff, Demin Wang, Subramaniam Malarkannan, Li Wang - Cancer Immunology Research 2019 cited by 186

  9. Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis

    Authors: Guang Yang, Ying Yuan, Hongfeng Yuan, Jiapei Wang, Haolin Yun, Yu Geng, Man Zhao, Linhan Li, Yejing Weng, Zixian Liu, Jinyan Feng, Yanan Bu, Lei Liu, Bingnan Wang, Xiaodong Zhang - EMBO Reports 2020 cited by 152

  10. Zinc Oxide Nanoparticles: Synthesis, Characterization, Modification, and Applications in Food and Agriculture

    Authors: Xianqing Zhou, Zakir Hayat, Dongdong Zhang, Mengyao Li, Hu Si, Qiong Wu, Yufei Cao, Ying Yuan - Processes 2023 cited by 333

  11. HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

    Authors: Yufei Wang, Man Zhao, Lina Zhao, Yu Geng, Guanghao Li, Lin Chen, Jingxuan Yu, Hongfeng Yuan, Huihui Zhang, Haolin Yun, Ying Yuan, Guowen Wang, Jinyan Feng, Liang Xu, Shuai Wang, Chunyu Hou, Guang Yang, Ningning Zhang, Wei Lü, Xiaodong Zhang - Cancer Research 2023 cited by 111

  12. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages

    Authors: John de Groot, Marta Peñas-Prado, Kristin Alfaro-Munoz, Kathy Hunter, Be Lian Pei, Barbara O’Brien, Shiao-Pei Weathers, Monica Loghin, Carlos Kamiya Matsouka, W.K. Alfred Yung, Jacob Mandel, Jimin Wu, Ying Yuan, Shouhao Zhou, Gregory N. Fuller, Jason T. Huse, Ganesh Rao, Jeffrey S. Weinberg, Sujit S. Prabhu, Ian E. McCutcheon, Frederick F. Lang, Sherise D. Ferguson, Raymond Sawaya, Rivka R. Colen, Shalini S. Yadav, Jorge Blando, Luis M. Vence, James P. Allison, Padmanee Sharma, Amy B. Heimberger - Neuro-Oncology 2019 cited by 166

  13. O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins

    Authors: Yulin Chen, Ruixi Wan, Zhongyu Zou, Lihui Lao, Guojian Shao, Yingying Zheng, Ling Tang, Ying Yuan, Yun Ge, Chuan He, Shixian Lin - Nature Cell Biology 2023 cited by 117

  14. Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis

    Authors: Yunben Yang, Lili Li, Chunjing Xu, Yunke Wang, Zhen Wang, Mengyao Chen, Jiang Zhou, Jun Pan, Chenghui Yang, Xiaoqian Li, Kai Song, Junfeng Yan, Wanglan Xie, Xianguo Wu, Zhigang Chen, Ying Yuan, Shu Zheng, Jun Yan, Jian Huang, Fuming Qiu - Gut 2020 cited by 159

  15. Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors

    Authors: Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, David Liu, Lin Shen - Journal of Hematology & Oncology 2021 cited by 146

  16. Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

    Authors: Siqing Fu, Shuyang Yao, Yuan Yuan, Rebecca A. Previs, Anthony Elias, Richard D. Carvajal, Thomas J. George, Ying Yuan, Lihou Yu, Shannon N. Westin, Yan Xing, Ecaterina E. Dumbrava, Daniel D. Karp, Sarina A. Piha‐Paul, Apostolia M. Tsimberidou, Jordi Rodón, Naoko Takebe, Karen H. Lu, Khandan Keyomarsi, Funda Meric‐Bernstam - Journal of Clinical Oncology 2022 cited by 94

  17. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

    Authors: Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Michael Rubin, Ying Yuan, Diana Bell, Adel K. El‐Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross - Clinical Cancer Research 2021 cited by 138

  18. RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis

    Authors: Hui Chen, Yinshuang Li, Jianfeng Wu, Guoping Li, Xuan Tao, Kunmei Lai, Ying Yuan, Xiaohong Zhang, Zhenhuan Zou, Yanfang Xu - Cell Death and Differentiation 2020 cited by 131

  19. Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

    Authors: Lionel Adès, Larisa Girshova, Vadim Doronin, María Díez‐Campelo, David Valcárcel, Suman Kambhampati, Nora‐Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Αchilles Anagnostopoulos, Eduardo Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres - Blood Advances 2022 cited by 121

  20. Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials

    Authors: Johnique T. Atkins, Goldy C. George, Kenneth R. Hess, Kathrina L. Marcelo-Lewis, Ying Yuan, Gautam Borthakur, Sean Khozin, Patricia LoRusso, David S. Hong - British Journal of Cancer 2020 cited by 120

  21. Directed-evolution of translation system for efficient unnatural amino acids incorporation and generalizable synthetic auxotroph construction

    Authors: Hongxia Zhao, Wenlong Ding, Jia Zang, Yang Yang, Chao Liu, Linzhen Hu, Yulin Chen, Guanglong Liu, Fang Yu, Ying Yuan, Shixian Lin - Nature Communications 2021 cited by 65

  22. Clinical and Molecular Characterization ofPOLEMutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers

    Authors: Benjamin Garmezy, Jinesh Gheeya, Heather Y. Lin, Yuefan Huang, Taebeom Kim, Xianli Jiang, Kyaw Z. Thein, Patrick G. Pilié, Fadl Zeineddine, Wanlin Wang, Kenna R. Shaw, Jordi Rodon, John Paul Shen, Ying Yuan, Funda Meric-Bernstam, Ken Chen, Timothy A. Yap - JCO Precision Oncology 2022 cited by 108

  23. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

    Authors: Adriana Olar, Khalida Wani, Kristin Alfaro-Munoz, Lindsey Heathcock, Hinke F. van Thuijl, Mark R. Gilbert, Terri S. Armstrong, Erik P. Sulman, Daniel P. Cahill, Elizabeth Vera‐Bolanos, Ying Yuan, Jaap C. Reijneveld, Bauke Ylstra, Pieter Wesseling, Kenneth Aldape - Acta Neuropathologica 2015 cited by 351

  24. Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study

    Authors: Jianming Xu, Lin Shen, Zhiwei Zhou, Jie Li, Chunmei Bai, Yihebali Chi, Zhiping Li, Nong Xu, Enxiao Li, Tianshu Liu, Yuxian Bai, Ying Yuan, Xingya Li, Xiuwen Wang, Jia Chen, Jieer Ying, Xianjun Yu, Shukui Qin, Xianglin Yuan, Tao� Zhang, Yanhong Deng, Dianrong Xiu, Ying Cheng, Min Tao, Ru Jia, Wei Wang, Jing Li, Songhua Fan, Mengye Peng, Weiguo Su - The Lancet Oncology 2020 cited by 190